Literature DB >> 21412507

Vaccination coverage in immunosuppressed patients: results of a regional health services research study.

Niels Teich1, Tobias Klugmann, Astrid Tiedemann, Babett Holler, Joachim Mössner, Anke Liebetrau, Ingolf Schiefke.   

Abstract

BACKGROUND: Patients with chronic inflammatory diseases are at elevated risk of infections that can be prevented by vaccination. This elevated risk is due not just to these patients' primary illnesses, but also to the immunosuppressive treatment that they often receive. We studied the vaccination rate in a random sample of patients with two types of inflammatory bowel disease (IBD), namely, Crohn's disease and ulcerative colitis. In particular, we asked unvaccinated patients why they had re-fused the vaccine.
METHODS: From April to September 2009, we gave a 38-item questionnaire to 203 consecutive patients with IBD (57% with Crohn's disease, 63% female, median age 36 years) who had not received vaccination counseling for at least one year, and inspected the patients' vaccination cards. We compared the findings to the current recommendations of the German Federal Standing Committee on Vaccination (Ständige Impfkommission).
RESULTS: 83% of the patients had a vaccination card. Substantial deficiencies in vaccination were found. Only 67% of the patients had been immunized against tetanus in the previous 10 years, and only 21% against pertussis. Only 28% were vaccinated against seasonal influenza in 2008, and only 9% had ever received anti-pneumococcal vaccine. A subgroup analysis in which we compared 39 patients taking TNF-blockers to 67 patients who never had any type of immunosuppressive treatment revealed no difference in vaccination rates. 80% of all patients said they were willing to receive all of the officially recommended vaccinations. 22% of all patients said they avoided vaccinations for fear of side effects, while 15% said they did so because their immune system was supposedly "not intact", and 9% because they feared vaccination would worsen their IBD.
CONCLUSION: In this random sample, the vaccination rate fell far behind the recommendations. In particular, there was a marked discrepancy between patients' willingness to be vaccinated and the actual provision of vaccination. These findings imply that physicians need to be more aware of the possibly inadequate vaccination state of their immunosuppressed patients.

Entities:  

Mesh:

Year:  2011        PMID: 21412507      PMCID: PMC3057621          DOI: 10.3238/arztebl.2011.0105

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  21 in total

1.  Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease.

Authors:  M A Ritz; R Jost
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

2.  Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.

Authors:  Gil Y Melmed; Andrew F Ippoliti; Konstantinos A Papadakis; Tram T Tran; Jaime L Birt; Susie K Lee; Robert W Frenck; Stephan R Targan; Eric A Vasiliauskas
Journal:  Am J Gastroenterol       Date:  2006-06-30       Impact factor: 10.864

3.  Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.

Authors:  Jean-Baptiste Chevaux; Abdelbasset Nani; Abderrahim Oussalah; Véronique Venard; Mouni Bensenane; Arthur Belle; Jean-Louis Gueant; Marc-André Bigard; Jean-Pierre Bronowicki; Laurent Peyrin-Biroulet
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

4.  [Not Available].

Authors:  A Dippelhofer; C Meyer; P Kamtsiuris; G Rasch; S Reiter; K E Bergmann
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2002-04       Impact factor: 1.513

5.  Low prevalence of prior streptococcus pneumoniae vaccination among potential lung transplant candidates.

Authors:  Leanne B Gasink; Alysse G Wurcell; Robert M Kotloff; Ebbing Lautenbach; Emily A Blumberg
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

6.  Overwhelming pneumococcal septicaemia in a patient with ulcerative colitis and splenic atrophy.

Authors:  K J Foster; N Devitt; P J Gallagher; R M Abbott
Journal:  Gut       Date:  1982-07       Impact factor: 23.059

Review 7.  Immunizations in patients with inflammatory bowel disease.

Authors:  Ying Lu; Denise Jacobson; Athos Bousvaros
Journal:  Inflamm Bowel Dis       Date:  2009-09       Impact factor: 5.325

8.  Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases.

Authors:  Saad B Omer; Daniel A Salmon; Walter A Orenstein; M Patricia deHart; Neal Halsey
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

9.  Higher incidence of abnormal Pap smears in women with inflammatory bowel disease.

Authors:  Sunanda Kane; Bahar Khatibi; Deepa Reddy
Journal:  Am J Gastroenterol       Date:  2007-10-17       Impact factor: 10.864

10.  Evaluation of the vaccination status in pediatric renal transplant recipients.

Authors:  T S S Chaves; L M Pereira; S S De Santos; E David-Neto; M H Lopes
Journal:  Pediatr Transplant       Date:  2008-06
View more
  17 in total

1.  Correspondence (letter to the editor): Particular characteristics of encapsulated bacteria.

Authors:  Maximilian Christopeit; Martin Graubner; Andrew J Ullmann
Journal:  Dtsch Arztebl Int       Date:  2011-12-09       Impact factor: 5.594

2.  Correspondence (letter to the editor): Clarifications.

Authors:  Jan Leidel
Journal:  Dtsch Arztebl Int       Date:  2011-12-09       Impact factor: 5.594

3.  Correspondence (letter to the editor): Limitations.

Authors:  Herbert Hof; Jan Bartel
Journal:  Dtsch Arztebl Int       Date:  2011-12-09       Impact factor: 5.594

4.  [Insufficient tetanus vaccination protection in psoriasis and systemic immunosuppression : Results of a retrospective investigation of 101 patients].

Authors:  W Sondermann; L Leister; N Rompoti; J Dissemond; J Klode; A Körber
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

5.  [Practical problems by implementation of vaccination recommendations].

Authors:  C Fendler; E Saracbasi; F Dybowski; F Heldmann; J Braun
Journal:  Z Rheumatol       Date:  2012-02       Impact factor: 1.372

Review 6.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

7.  Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice-results of a non-representative survey.

Authors:  Lea I Kredel; Oliver Schneidereit; Jörg C Hoffmann; Britta Siegmund; Jan C Preiß
Journal:  Int J Colorectal Dis       Date:  2018-12-07       Impact factor: 2.571

Review 8.  Vaccination in Patients with Inflammatory Bowel Diseases.

Authors:  Christine N Manser; Michel H Maillard; Gerhard Rogler; Philipp Schreiner; Florian Rieder; Silja Bühler
Journal:  Digestion       Date:  2020-01-22       Impact factor: 3.216

Review 9.  Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.

Authors:  Alicia C Marín; Javier P Gisbert; María Chaparro
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

10.  Immunization status in children with inflammatory bowel disease.

Authors:  Romain Longuet; Stephanie Willot; Jean-Louis Giniès; Cecile Pélatan; Estelle Breton; Jean-François Segura; Laure Bridoux; Gaelle Le Henaff; Benoit Cagnard; Agathe Jobert; Joël Cardonna; Isabelle Grimal; Martine Balençon; Estelle Darviot; Nadège Delaperrière; Dominique Caldari; Hugues Piloquet; Alain Dabadie
Journal:  Eur J Pediatr       Date:  2013-12-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.